Physician profile
Ross Winakor
NPI 1720071681
$5,160.51
in general payments reported to CMS, 2019-2025
48 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $728 · 2021: $1,206 · 2022: $919 · 2023: $749 · 2024: $606 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692 · Education: $8.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.48 |
| Education | $8.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $556.68 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $519.79 | 2019-2025 | Breztri, Bevespi Aerosphere, Farxiga |
| Abbvie INC. | $438.50 | 2020-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.52 | 2019-2022 | |
| Lilly USA, LLC | $372.78 | 2019-2024 | Mounjaro, Zepbound |
| Pfizer INC. | $336.83 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $266.89 | 2019-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Glaxosmithkline, LLC. | $172.06 | 2019-2023 | Shingrix, Arexvy |
| Eisai INC. | $166.65 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.09 | 2022-2024 | |
| Exact Sciences Corporation | $132.16 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $109.50 | 2019-2025 | Prolia, Evenity, Otezla |
| Otsuka America Pharmaceutical, INC. | $109.13 | 2022-2025 | Rexulti |
| Sanofi Pasteur INC. | $102.20 | 2023-2025 | |
| Allergan, INC. | $99.14 | 2019-2020 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Winakor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.